Regulation of β2-microglobulin expression in different human cell lines by proinflammatory cytokines

Nephrology Dialysis Transplantation

Volumn 14, Issue 9, 1999, Pages 2137-2143

  Vraetz, Thomas ^a   Ittel, Thomas H ^a,b   Van Mackelenbergh, Michelle G ^a   Heinrich, Peter C ^a   Sieberth, H G ^a   Graeve, Lutz ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b Department of Internal Medicine   (Germany)

Author keywords

2 microglobulin amyloidosis; Bioincompatibility; Cytokines; Hepatoma cells; Interleukin 6; Long term haemodialysis

Indexed keywords

ALPHA INTERFERON; BETA 2 MICROGLOBULIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; AUTACOID; INTERLEUKIN 1;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HEPATOMA CELL; HUMAN; HUMAN CELL; INFLAMMATION; LEUKEMIA CELL LINE; MONOCYTE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SYNOVIOCYTE; T LYMPHOCYTE; CELL LINE; CULTURE MEDIUM; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY;

BETA 2-MICROGLOBULIN; CELL LINE; CULTURE MEDIA; CYTOKINES; GENE EXPRESSION; HUMANS; INFLAMMATION MEDIATORS; INTERFERON TYPE II; INTERFERON-ALPHA; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MONOCYTES;

EID: 0032588582     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.9.2137     Document Type: Article

References (45)

1. Koch KM. Dialysis-related amyloidosis. Kidney Int 1992; 41: 1416-1429
2. Drüeke TB. Dialysis-related amyloidosis. Nephrol Dial Transplant 1998; 13 [Suppl 1]: 58-64
3. Hakim RM. Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 1993; 44: 484-494
4. 2-microglobulin kinetics in end-stage renal failure. Kidney Int 1991; 39: 909-919
5. 2-Microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis? Kidney Int 1997; 52: 1077-1083
6. Ghysen J, De Plaen JF, van Ypersele de Strihou C. The effect of membrane characteristics on tumor necrosis factor kinetics during haemodialysis. Nephrol Dial Transplant 1990; 5: 270-274
7. Deppisch R, Ritz E, Hänsch GM, Schöls M, Rauterberg EW. Bioincompatibility - perspectives in 1993. Kidney Int 1994; 45 [Suppl 44]: S77-S84
8. Nachbaur K, Troppmair J, Bieling P, Kotlan B, König P, Huber CH. Cytokines in the control of beta-2 microglobulin release. I. In vitro studies on various haematopoietic cells. Immunobiology 1988, 177: 55-65
9. Nachbaur K, Troppmair J, Kotlan B et al. Cytokines in the control of beta-2 microglobulin release. II. In vivo studies with recombinant interferons and antigens. Immunobiology 1988; 177: 66-75
10. Lovett D, Kozan B, Hadam M, Resch K, Gemsa D. Macrophage cytoloxicity: interleukin-1 as a mediator of tumor cytostasis. J Immunol 1986; 136: 340-347
11. Memoli B, Libetta C, Rampino T et al. Interleukin-6 production of uraemic haemodialysed patients: effects of different membranes. Nephrol Dial Transplant 1991 [Suppl 2]: 96-98
12. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990; 265: 621-636
13. Wegenka UM, Buschmann J, Lütticken C, Heinrich PC, Horn F. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol Cell Biol 1993; 13: 276-288
14. Lütticken C, Wegenka UM, Yuan J et al. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 1994; 263: 89-92
15. Homma T, Tsujinaka T, Kido Y, Yasuda T, Murata A, Mon T. Secretion of beta-2-microglobulin from human hepatoblastoma and hepatoma cells on stimulation with interleukin-6. Eur Surg Res 1992; 24: 204-210
16. Arcone R, Pucci P, Zappacosta F et al. Single-step purification and structural characterization of human interleukin-6 produced in Escherichia coli from a T7 RNA polymerase expression vector. Eur J Biochem 1991; 198: 541-547
17. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
18. Böyum A et al. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest 1968; 97 [Suppl]: 77-89
19. Gesualdo L, Pertosa G, Grandaliano G, Schena FP. Cytokines and bioincompatibility. Nephrol Dial Transplant 1998; 13: 1622-1626
20. Memoli B, Libetta C, Rampino T. Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells. Kidney Int 1992; 42: 320-326
21. Libetta C, De NL, Rampino T, De SW, Memoli B. Inflammatory effects of peritoneal dialysis: evidence of systemic monocyte activation. Kidney Int 1996; 49: 506-511
22. Miyasaka N, Sato K, Kitano Y, Higaki M, Nishioka K, Ohta K. Aberrant cytokine production from tenosynovium in dialysis associated amyloidosis. Ann Rheum Dis 1992; 51: 797-802
23. Carreno MP, Rousseau Y, Poignet JL. Dissociation between beta-2 microglobulin and IL-1 production in hemodialyzed patients. Nephrol Dial Transplant 1997; 12: 1365-2374
24. Herbelin A, Ureña P, Nguyen AT, Zingraff J, Descamps-Latscha B. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int 1991; 39: 954-960
25. Pertosa G, Gesualdo L, Tarantino EA, Ranieri E, Bottalico D, Schena FP. Influence of hemodialysis on interleukin-6 production and gene expression by peripheral blood mononuclear cells. Kidney Int 1993; 43 [Suppl 39]: S149-S153
26. Pertosa G, Gesualdo L, Bottalico D, Schena FP. Endotoxins modulate chronically tumour necrosis factor a and interleukin 6 release by uraemic monocytes. Nephrol Dial Transplant 1995; 10: 328-333
27. Vaziri ND, Wang J, Cesario T, Yousefi S, Valenzuela R, Carandang G. Induction, transcription, synthesis, and adsorption of interleukin-1 by dialyzer membranes. J Am Soc Nephrol 1994; 4: 1884-1889
28. Mege JL, Capo C, Purgus R, Olmer M. Monocyte production of transforming growth factor beta in long-term hemodialysis: modulation by hemodialysis membranes. Am J Kidney Dis 1996; 28: 395-399
29. Oettinger CW, Bland LA, Oliver JC, Arduino MJ, McAllister K, Favero MS. The effect of uremia on tumor necrosis factor-alpha release after an in vitro whole-blood endotoxin challenge. J Am Soc Nephrol 1994; 4: 1890-1895
30. Pereira BJG, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA. Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 1994; 45: 890-896
31. Schindler R, Lonnemann G, Shaldon S, Koch KM, Dinarello CA. Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 1990; 37: 85-93
32. Girndt M, Köhler H, Schiedhelm-Weick E, Schlaak JF, Meyer zum Büschenfelde KH, Fleischer B. Production of interleukin-6, tumor necrosis factor α and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int 1995; 47: 559-565
33. Engelberts I, Francot GJM, Leunissen KML et al. Effect of hemodialysis on peripheral blood monocyte tumor necrosis factor-α, interleukin-6, and interleukin-8 secretion in vitro. Nephron 1994; 66: 396-403
34. Paczek L, Schaefer RM, Heidland A. Dialysis membranes decrease immunoglobulin and interleukin-6 production by peripheral blood mononuclear cells in vitro. Nephrol Dial Transplant 1991; [Suppl 3]: 41-44
35. Leimenstoll G, Zabel P, Birkner T, Heyl K, Preusse D, Niedermayer W. Effect of renal function on cytokine secretion of monocytes and lymphocytes. Nephrol Dial Transplant 1994; 9: 493-498
36. Pertosa G, Grandaliano G, Gesualdo L, Ranieri E, Monno R, Schena FP. Interleukin-6, interleukin-8, and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes. Kidney Int 1998; 54: 570-579
37. Zaoui P, Hakim RM. The effects of the dialysis membrane in cytokine release. J Am Soc Nephrol 1994; 4: 1711-1718
38. Hayakawa M, Hatano T, Sunabe T, Higa I, Osawa A. Cytokine production and cytotoxicity of lymphocytes in patients on maintenance short-or long-term haemodialysis. Nephrol Dial Transplant 1994; 9: 655-661
39. Lonergan M, Dey A, Becker KG, Drew PD, Ozato K. A regulatory element in the beta 2-microglobulin promoter identified by in vivo footprinting. Mol Cell Biol 1993; 13: 6629-6639
40. 2-microglobulin, neopterin and interferon-αin patients treated with recombinant tumor necrosis factor-α. J Interferon Res 1988; 8: 655-664
41. Ramadori G, Mitsch A, Rieder H, Meyer zum Büschenfelde KH. Alpha-and gamma-interferon (IFN alpha, IFN gamma) but not interleukin-1 (IL-1) modulate synthesis and secretion of beta 2-microglobulin by hepatocytes. Eur J Clin Invest 1988; 18: 343-351
42. + T cells. J Exp Med 1997; 185: 461-469
43. Dasgupta MK. Biofilm causes decreased production of interferon-gamma. J Am Soc Nephrol 1996; 7: 877-882
44. Grooteman MPC, Nubé MJ, van Limbeck J, Schoorl M, van Houte AJ. Lymphocyte subsets in dialyser eluates: a new parameter of bioincompatibility? Nephrol Dial Transplant 1996; 11: 1073-1078
45. Kumano K, Nanbu M, Kusakari S, Sakai T. Beta 2-microglobulin synthesis of mononuclear cells in chronic dialysis patients. Int J Artif Org 1992; 15: 401-407